发明名称 |
<i>Vibrio cholerae</i> O139 conjugate vaccines |
摘要 |
The disclosure pertains to conjugates of the capsular polysaccharide of Vibrio cholerae O139, or a structurally and/or immunologically related oligo- or poly-saccharide, and a carrier. These conjugates are useful as pharmaceutical compositions and/or vaccines to induce serum antibodies which have bactericidal (vibriocidal) activity against V. cholerae, in particular V. cholerae O139, and are useful to prevent, treat and/or reduce the severity of disease caused by V. cholerae infection, such as cholera. The present disclosure also relates to diagnostic tests for V. cholerae infection, and/or cholera caused by V. cholerae infection, using one or more of the oligo- or poly-saccharide-carrier conjugates or antibodies described above. |
申请公布号 |
US8852605(B2) |
申请公布日期 |
2014.10.07 |
申请号 |
US200711695735 |
申请日期 |
2007.04.03 |
申请人 |
The United States of America as represented by the Secretary of the Department of Health and Human Services |
发明人 |
Szu Shousun Chen;Kossaczka Zuzana;Robbins John B. |
分类号 |
A61K39/00;A61K39/38;A61K39/40;A61K39/385;A61K39/116;A61K39/02;A61K39/106;A61K38/00;A61K38/16;A61K39/395;A61K31/415;A01N43/46 |
主分类号 |
A61K39/00 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A conjugate molecule, consisting essentially of the capsular polysaccharide of Vibrio cholera O139, hydroxyl coupled to a adipic acid hydrazide-recombinant diphtheria toxin mutant CRMH21G carrier protein, wherein the polysaccharide to protein ratio is about 0.90 and the conjugated molecule elicits serum antibodies vibriocidal to Vibrio cholera O139 and diphtheria. |
地址 |
Washington DC US |